Mirae Asset Global Investments
GWPH

Mirae Asset Global Investments’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Mirae Asset Global Investments’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-240,205
Closed -$52.1M – 1763
2021
Q1 		$52.1M Sell
240,205
-88,545
-27% -$16.6M 0.18% 147
2020
Q4 		$37.9M Buy
328,750
+4,389
+1% +$492K 0.14% 178
2020
Q3 		$31.6M Buy
324,361
+7,458
+2% +$858K 0.16% 149
2020
Q2 		$38.9M Buy
316,903
+23,280
+8% +$2.64M 0.23% 96
2020
Q1 		$25.7M Sell
293,623
-22,222
-7% -$2.35M 0.2% 104
2019
Q4 		$33M Sell
315,845
-281,559
-47% -$31.6M 0.2% 112
2019
Q3 		$68.7M Buy
597,404
+23,225
+4% +$3.53M 0.48% 31
2019
Q2 		$99M Buy
574,179
+561,036
+4,269% +$97M 0.68% 26
2019
Q1 		$2.22M Sell
13,143
-8,089
-38% -$1.2M 0.02% 616
2018
Q4 		$2.07M Sell
21,232
-34
-0.2% -$4.46K 0.02% 603
2018
Q3 		$3.67M Buy
21,266
+10,493
+97% +$1.51M 0.03% 492
2018
Q2 		$1.5M Sell
10,773
-8,707
-45% -$1.24M 0.02% 439
2018
Q1 		$2.19M Sell
19,480
-227,310
-92% -$28.6M 0.03% 352
2017
Q4 		$32.6M Buy
246,790
+138,199
+127% +$16.2M 0.44% 46
2017
Q3 		$11M Buy
108,591
+14,776
+16% +$1.58M 0.2% 98
2017
Q2 		$9.41M Buy
93,815
+83,658
+824% +$9M 0.16% 99
2017
Q1 		$1.23M Buy
10,157
+4,860
+92% +$596K 0.02% 347
2016
Q4 		$592K Buy
+5,297
New +$638K 0.01% 378

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Mirae Asset Global Investments's GWPH Position: Q2 2021 in Review

Mirae Asset Global Investments sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 240,205 shares — an estimated $52.1M sold.

Mirae Asset Global Investments first reported a position in GWPH in Q4 2016 and held it in 18 quarters. The position peaked at $99M in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Mirae Asset Global Investments reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Mirae Asset Global Investments sold 240,205 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $52.1M.
  • Mirae Asset Global Investments first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 18 quarters.
  • Mirae Asset Global Investments's GW Pharmaceuticals Plc American Depositary Shares position peaked at $99M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Mirae Asset Global Investments's 13F filing for Q2 2021, filed 11 Aug 2021.